Takara Bio Inc., develops, manufactures, and distributes a wide range of life science reagents and kits under the Takara®, Clontech®, and Cellartis® brands. Key products include SMART® cDNA synthesis kits for a variety of samples and applications, including NGS; high-performance qPCR and PCR reagents (including the Takara Ex Taq®, Takara LA Taq®, Titanium®, and Advantage® enzymes); Cellartis stem cells and stem cell reagents; RT enzymes and SMART library construction kits; the innovative In-Fusion® cloning system; Guide-it™ gene editing tools; Tet-based inducible gene expression systems; and Living Colors® fluorescent proteins. These and other products support applications including NGS; gene discovery, regulation, and function studies; protein expression and purification; RNAi, gene editing, and stem cell studies; and plant and food research

The Max Planck Society for the Advancement of Science (German: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V.; abbreviated MPG) is a non-governmental and non-profit association of Research Institutes publicly funded by the federal and the state governments of Germany. Additionally, the Max Planck Society and its Institutes receive third party funding from public and private contributions and from the European Union. The world leading organization is named in honor of its former president, theoretical physicist Max Planck. The 86 Institutes and Research Facilities of the Max Planck Society (as of 2020) conduct basic research in the natural sciences, life sciences, social sciences, and the arts and humanities. They have a total staff of approximately 24,000 permanent employees, including 15,000 scientists, and around 5,000 non-tenured scientists and guests. As of December 31, 2018, the proportion of female employees was 44.4 percent. The Max Planck Society (with its 86 Max Planck Institutes) has a world-leading reputation as a science and technology research organization, with more than 33 Nobel Prizes awarded to its scientists, and is widely regarded as one of the foremost basic research organizations in the world.

B·R·A·H·M·S explores, develops and produces new diagnostic test procedures to improve the diagnosis, and thereby the treatment, of life-threatening illnesses. This takes place with over 400 employees, on the basis of their own patented biomarkers, and leads to medically and economically superior diagnostic insights for patients and medical professionals. B·R·A·H·M·S products reach customers in over 65 countries around the world and are leaders in their specialized markets.

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. In 2018, the company's largest selling product lines were Neulasta, an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.

Teijin Ltd. engages in the management of its group companies that are involved in the environment and energy, safety and protection, information and electronics, transportation, and healthcare businesses. It operates through the following segments: Materials, Healthcare, and Others. The Materials segment handles the manufacture and sale of polyester, aramid, and carbon fiber products as well as plastic and resin products from polycarbonate resin and polyester film. The Healthcare segment deals with the manufacture and sale of pharmaceuticals and home medical equipment. It also provides home healthcare services. The Others segment offers information technology services. The company was founded by Seita Kumura, Itsuzo Hata, and Naokichi Kaneko on June 17, 1918 and is headquartered in Osaka, Japan.

Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration

Behringwerke AG, a subsidiary of Sanofi, is a German company located in Marburg. The firm produces specialty chemicals and pharmaceutical products.

Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany.

Shanghai Lianji Medical Laboratory Co., Ltd., established on 2013-12-03, Business scope includes licensed projects:medical service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Medical Laboratory(Clinical Cytomolecular Genetics Major),laboratory reagent,biomedicine,Technology development in the field of bioengineering,Transfer of self-research results,and provide related consulting services,Health Information Consultation.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Takara Shuzo Co. Ltd. manufactures and markets alcoholic beverages. Its products include alcoholic beverages, raw alcohol, health drinks, and seasonings. The company was founded in 1925 and is headquartered in Kyoto, Japan.

Shanghai Institutes for Biological Sciences CAS is a private company headquartered in Shanghai, China, that operates as researching agency.

Jiangsu Nandian Smart Energy Service Co., Ltd., established on 2019-03-04, Business scope includes new energy technology development;Investment in Energy Projects(Does not include finance,Financial business),the construction,to run,maintain,consultation service;Energy-saving system engineering,Construction of mechanical and electrical equipment installation works;Contract Energy Management;air conditioner,Power distribution equipment maintenance;Power Electrical Equipment and Systems,Electronic Component,electronic product,Instrumentation Design,research and development,Sales,Technical Services;Computer system integration and technical services;Computer software development,Sales,Technical Services;Research and development of oil fume purifier,Sales;data service;electricity sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Supply Instrumentation Manufacturing;Instrument Manufacturing;Manufacturing of experimental analysis instruments(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Engages in developing, producing and selling pharmaceutical and chemical products

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany.

Nisshin Flour Milling, Inc. manufactures and sells wheat flour. It supplies wheat flour and premix products for manufacturing use, as well as other related products such as wheat bran, wheat germ and rye. The company was founded in 1908 and is located in Tokyo, Japan

Jingxi Xiumei Biancheng Agricultural Technology Co., Ltd., established on 2016-05-20, Business scope includes agricultural planting technology,Animal husbandry technology development and application services;Agricultural tourism project development;fruit,cereals,Planting and sales of vegetables;Breeding and sales of freshwater aquatic products;Energy-saving products,Environmentally friendly products,Agricultural and sideline products,Daily necessities,Equipment,feed,Seedlings,Fertilizer sales;Equipment,Manufacturing and sales of electronic products;information Technology,energy saving technology,Environmental Technology,Pharmaceutical biotechnology development and service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)